Skip to content

Drug interactions

Fedratinib + Rolapitant

Severity: Minor

Fedratinib and Rolapitant: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Fedratinib is a moderate CYP3A4 inhibitor, and rolapitant is metabolized in part by CYP3A4, so rolapitant concentrations may rise. Fedratinib also inhibits CYP2D6, which could increase exposure to certain other substrates, but this is not specific here.

What this interaction means in plain words

Fedratinib and Rolapitant have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Fedratinib belongs to Oncology; Rolapitant belongs to Gastrointestinal Tract.

Evidence level: Low

Why it happens

Fedratinib inhibits CYP3A4, possibly reducing rolapitant clearance.

What to do

No dose adjustment is generally needed; monitor for rolapitant adverse effects such as fatigue and dizziness.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Fedratinib and Rolapitant, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Fedratinib with Rolapitant?

MediHelp rates the interaction as minor. Fedratinib and Rolapitant have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Fedratinib is a moderate CYP3A4 inhibitor, and rolapitant is metabolized in part by CYP3A4, so rolapitant concentrations may rise. Fedratinib also inhibits CYP2D6, which could increase exposure to certain other substrates, but this is not specific here.

How serious is the interaction between Fedratinib and Rolapitant?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose adjustment is generally needed; monitor for rolapitant adverse effects such as fatigue and dizziness.

What other medicines interact with Rolapitant?

MediHelp also lists interactions of Rolapitant with, for example, Pimozide, Thioridazine, Atomoxetine. The full list is on the Rolapitant page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in